NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NPCE is expected to report earnings to rise 68.18% to -18 cents per share on March 10
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.09
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.07
The last earnings report on November 04 showed earnings per share of -10 cents, beating the estimate of -20 cents. With 120.56K shares outstanding, the current market capitalization sits at 428.00M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NPCE showed earnings on November 04, 2025. You can read more about the earnings report here.